keynote trial data: pembrolizumab’s role in nsclc
Published 6 years ago • 250 plays • Length 8:19Download video MP4
Download video MP3
Similar videos
-
2:30
dr. lopes on the keynote-042 results of frontline pembrolizumab in nsclc
-
1:48
results of keynote-024 trial of pembrolizumab in nsclc
-
5:54
pembrolizumab in newly diagnosed squamous nsclc
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...
-
4:47
benefit of pembrolizumab in nsclc: the keynote trials
-
3:31
the keynote-024 precedent for advanced-nsclc treatment
-
5:00
implications for pembrolizumab in nsclc
-
4:05
pembrolizumab chemotherapy in newly diagnosed nsclc
-
1:55
dr. kim on the keynote-189 trial in metastatic nsclc
-
1:22
updated outcomes of keynote-010 of pembrolizumab for nsclc
-
1:18
dr. reck on the safety of pembrolizumab in keynote-024 in metastatic nsclc
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
3:07
the keynote-001 trial: a breakthrough for pembrolizumab
-
2:25
dr. gadgeel on updated keynote-189 data in nsclc
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc
-
1:50
dr. levy discusses pembrolizumab in nsclc
-
5:42
keynote-189: chemotherapy and pembrolizumab in mnsclc
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
2:44
pembrolizumab and chemotherapy in advanced nsclc